Publication | Closed Access
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
88
Citations
31
References
2016
Year
Vigil® DnaMedicineImmunologyPhase Ii StudyImmune Checkpoint InhibitorGene VectorCancer TreatmentImmune Cell TherapyImmunotherapyOncologyRadiation OncologyOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1